Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
RXD
Upturn stock ratingUpturn stock rating

ProShares UltraShort Health Care (RXD)

Upturn stock ratingUpturn stock rating
$12.01
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

07/09/2025: RXD (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit 0%
Avg. Invested days 0
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/09/2025

Key Highlights

Volume (30-day avg) -
Beta -1.05
52 Weeks Range 9.11 - 13.64
Updated Date 06/29/2025
52 Weeks Range 9.11 - 13.64
Updated Date 06/29/2025

ai summary icon Upturn AI SWOT

ProShares UltraShort Health Care

ETF Overview

overview logo Overview

ProShares UltraShort Health Care (RXD) seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index. It is a leveraged inverse ETF designed for short-term trading.

reliability logo Reputation and Reliability

ProShares is a well-known issuer of leveraged and inverse ETFs, with a solid reputation for managing these complex products.

reliability logo Management Expertise

ProShares has considerable experience in managing leveraged and inverse funds, requiring specialized knowledge in derivatives and hedging strategies.

Investment Objective

overview logo Goal

To provide daily investment results (before fees and expenses) that correspond to two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index.

Investment Approach and Strategy

Strategy: The ETF employs a leveraged inverse strategy, using derivatives to achieve -2x the daily performance of its underlying index.

Composition The ETF primarily holds financial instruments, such as swap agreements, futures contracts, and money market instruments, designed to create inverse leveraged exposure to the healthcare sector.

Market Position

Market Share: RXD's market share is relatively small due to its leveraged inverse nature and niche application.

Total Net Assets (AUM): 18880000

Competitors

overview logo Key Competitors

  • Direxion Daily Healthcare Bear 3X Shares (SICK)

Competitive Landscape

The competitive landscape is limited due to the specialized nature of leveraged inverse healthcare ETFs. RXD offers -2x leverage, while SICK offers -3x leverage, catering to different risk appetites. RXD's advantage lies in its established track record with ProShares, a respected issuer. A disadvantage is that this ETF is intended for short-term use only, not long-term.

Financial Performance

Historical Performance: Historical performance data is highly volatile and depends heavily on the daily movements of the Dow Jones U.S. Health Care Index. Past performance is not indicative of future results.

Benchmark Comparison: The ETF aims to achieve -2x the daily performance of the Dow Jones U.S. Health Care Index. Deviations may occur due to fees, expenses, and compounding effects.

Expense Ratio: 0.95

Liquidity

Average Trading Volume

The average trading volume of RXD suggests moderate liquidity, though it can vary based on market conditions.

Bid-Ask Spread

The bid-ask spread is typically moderate, but can widen during periods of high volatility or low trading volume.

Market Dynamics

Market Environment Factors

RXD is significantly influenced by news and events impacting the healthcare sector, broader market sentiment, and interest rate fluctuations.

Growth Trajectory

Given its leveraged inverse nature, RXD's growth trajectory is dependent on the direction and volatility of the healthcare sector. It is designed for short-term tactical trading, not long-term investing.

Moat and Competitive Advantages

Competitive Edge

RXD's competitive edge lies in its specific focus on providing -2x leveraged inverse exposure to the healthcare sector. ProShares' expertise in managing leveraged ETFs provides investors with confidence in the fund's structure and execution. However, its leveraged nature and sector focus expose it to amplified risks and limited diversification. This ETF is designed for investors seeking to profit from short-term declines in the healthcare sector, offering a tactical tool for specific market views.

Risk Analysis

Volatility

RXD exhibits high volatility due to its leveraged inverse structure. It's significantly more volatile than non-leveraged healthcare ETFs.

Market Risk

RXD is highly susceptible to market risk, particularly related to the healthcare sector's performance. Compounding effects can also significantly impact returns over longer periods.

Investor Profile

Ideal Investor Profile

RXD is suitable for sophisticated investors with a high-risk tolerance who understand the complexities of leveraged and inverse ETFs and have a short-term outlook on the healthcare sector.

Market Risk

RXD is best suited for active traders with a short-term investment horizon. It is not appropriate for long-term investors or passive index followers due to its high volatility and the potential for significant losses.

Summary

ProShares UltraShort Health Care (RXD) is a leveraged inverse ETF designed to provide -2x the daily performance of the Dow Jones U.S. Health Care Index. It is intended for sophisticated investors seeking short-term tactical exposure to declines in the healthcare sector. Due to its leveraged nature and volatility, RXD is not suitable for long-term investment and carries a high degree of risk. Investors should carefully consider their risk tolerance and investment objectives before investing in RXD.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • ProShares official website
  • ETF.com
  • Yahoo Finance
  • Bloomberg

Disclaimers:

This analysis is for informational purposes only and does not constitute investment advice. Investment decisions should be based on your own research and consultation with a financial advisor. Leveraged and inverse ETFs are complex financial instruments and involve significant risks, including the potential for complete loss of investment.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About ProShares UltraShort Health Care

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.